Needham & Company LLC Issues Pessimistic Forecast for Cognex (NASDAQ:CGNX) Stock Price

Cognex (NASDAQ:CGNX) had its price target cut by equities researchers at Needham & Company LLC from $80.00 to $70.00 in a report released on Friday, Benzinga reports. The firm presently has a “buy” rating on the scientific and technical instruments company’s stock. Needham & Company LLC‘s target price indicates a potential upside of 47.40% from the company’s previous close.

A number of other analysts also recently weighed in on CGNX. HSBC downgraded Cognex from a “buy” rating to a “hold” rating and set a $65.00 price target for the company. in a report on Monday, August 10th. DA Davidson reissued a “neutral” rating and issued a $65.00 price objective on shares of Cognex in a research note on Wednesday, September 23rd. Weiss Ratings upgraded Cognex from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, August 11th. Cantor Fitzgerald upped their target price on Cognex from $76.00 to $84.00 and gave the company an “overweight” rating in a research report on Friday, August 7th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and set a $91.00 target price on shares of Cognex in a research note on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $74.86.

Cognex Stock Down 10.5%

CGNX opened at $47.49 on Friday. Cognex has a twelve month low of $34.60 and a twelve month high of $72.88. The company has a fifty day moving average of $59.36 and a 200-day moving average of $57.99. The stock has a market cap of $7.99 billion, a PE ratio of 35.85 and a beta of 1.49.

Cognex (NASDAQ:CGNX) last announced its earnings results on Wednesday, November 4th. The scientific and technical instruments company reported $0.53 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.01. The business had revenue of $313.39 million during the quarter, compared to the consensus estimate of $313.62 million. Cognex had a net margin of 21.50% and a return on equity of 16.24%. Cognex’s quarterly revenue was up 13.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.33 earnings per share. Sell-side analysts anticipate that Cognex will post 1.68 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Eurizon Capital SGR S.p.A. increased its position in shares of Cognex by 111.8% during the 3rd quarter. Eurizon Capital SGR S.p.A. now owns 3,910 shares of the scientific and technical instruments company’s stock valued at $234,000 after purchasing an additional 2,064 shares during the last quarter. CENTRAL TRUST Co raised its stake in shares of Cognex by 960.4% during the 3rd quarter. CENTRAL TRUST Co now owns 2,916 shares of the scientific and technical instruments company’s stock worth $177,000 after purchasing an additional 2,641 shares during the period. Fifth Third Bancorp raised its stake in shares of Cognex by 28.6% during the 3rd quarter. Fifth Third Bancorp now owns 130,553 shares of the scientific and technical instruments company’s stock worth $7,918,000 after purchasing an additional 29,034 shares during the period. Maryland State Retirement & Pension System boosted its holdings in shares of Cognex by 12.1% in the 3rd quarter. Maryland State Retirement & Pension System now owns 9,927 shares of the scientific and technical instruments company’s stock worth $602,000 after buying an additional 1,071 shares during the last quarter. Finally, Ritholtz Wealth Management purchased a new position in shares of Cognex in the 3rd quarter worth about $208,000. 88.12% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Cognex

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Q3 adjusted earnings were $0.53 per share, ahead of estimates, while revenue rose 13% year over year to $313.4 million. The company cited strong automation demand, margin expansion and cost discipline. Cognex Q3 Earnings Beat on Strong Demand and Margin Expansion
• Positive Sentiment: Cognex raised its 2026 revenue outlook to $1.14 billion–$1.16 billion, a sign of confidence in demand and its growth prospects. Cognex forecasts 2026 revenue
• Positive Sentiment: The company announced a 5.9% increase in its quarterly dividend, to $0.09 per share. Cognex declares quarterly cash dividend
• Neutral Sentiment: Cognex plans to acquire RealSense, with the deal targeted to close in Q4. The acquisition could add growth opportunities, though integration and execution remain to be seen. Cognex reports third-quarter results and RealSense acquisition
• Negative Sentiment: Despite the earnings beat, Q3 revenue of $313.4 million came in just below analyst expectations. The stock’s decline suggests investors may have wanted a stronger beat or more compelling guidance. Cognex reports Q3 results in line with expectations

About Cognex

Cognex Corporation develops machine vision and industrial identification technologies that help manufacturers and businesses automate inspection, measurement, guidance, and tracking processes. Its systems use cameras, sensors, software, and artificial intelligence to analyze images and identify products, defects, components, and other objects.

The company’s product portfolio includes vision systems, industrial cameras, vision sensors, barcode readers, optical character recognition tools, three-dimensional vision systems, and machine vision software.